Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1903-1913

  O'Connor, Carla L ^a   Anguissola, Sergio ^a   Huber, Heinrich J ^a,b   Dussmann, Heiko ^a   Prehn, Jochen H M ^a   Rehm, Markus ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b Siemens Medical Division   (Ireland)

Author keywords

Apoptosis; Caspase; Fluorescence resonance energy transfer; Single cell analysis; Systems biology; XIAP

Indexed keywords

EFFECTOR CASPASE; STAUROSPORINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

ACCELERATION; APOPTOSIS; ARTICLE; CANCER CELL; CELL POPULATION; CELL STRAIN HCT116; COLON CANCER; COMET ASSAY; COMPUTATIONAL FLUID DYNAMICS; EPIFLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MITOCHONDRIAL PERMEABILITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASES; CELL LINE; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE DELETION; HUMANS; SIGNAL TRANSDUCTION; STAUROSPORINE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 50849123443     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.05.025     Document Type: Article

References (66)

1. G. Xu, Y. Shi, Apoptosis signaling pathways and lymphocyte homeostasis, Cell Res. (2007).
2. Adams J.M., and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007) 1324-1337
3. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
4. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., and Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
5. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
6. Dussmann H., Rehm M., Kogel D., and Prehn J.H. Outer mitochondrial membrane permeabilization during apoptosis triggers caspase-independent mitochondrial and caspase-dependent plasma membrane potential depolarization: a single-cell analysis. J. Cell. Sci. 116 (2003) 525-536
7. Goldstein J.C., Munoz-Pinedo C., Ricci J.E., Adams S.R., Kelekar A., Schuler M., Tsien R.Y., and Green D.R. Cytochrome c is released in a single step during apoptosis. Cell. Death Differ. 12 (2005) 453-462
8. Goldstein J.C., Waterhouse N.J., Juin P., Evan G.I., and Green D.R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell. Biol. 2 (2000) 156-162
9. Rehm M., Dussmann H., and Prehn J.H. Real-time single cell analysis of Smac/DIABLO release during apoptosis. J. Cell. Biol. 162 (2003) 1031-1043
10. Riedl S.J., and Salvesen G.S. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell. Biol. 8 (2007) 405-413
11. Kumar S. Caspase function in programmed cell death. Cell. Death Differ. 14 (2007) 32-43
12. Eckelman B.P., Salvesen G.S., and Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7 (2006) 988-994
13. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., and Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Embo J. 17 (1998) 2215-2223
14. Wu G., Chai J., Suber T.L., Wu J.W., Du C., Wang X., and Shi Y. Structural basis of IAP recognition by Smac/DIABLO. Nature 408 (2000) 1008-1012
15. Liu Z., Sun C., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., Herrmann J., Wu J.C., and Fesik S.W. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408 (2000) 1004-1008
16. Rehm M., Huber H.J., Dussmann H., and Prehn J.H. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. Embo J. 25 (2006) 4338-4349
17. Vogler M., Durr K., Jovanovic M., Debatin K.M., and Fulda S. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 26 (2007) 248-257
18. Jaffer S., Orta L., Sunkara S., Sabo E., and Burstein D.E. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma. Hum. Pathol. 38 (2007) 864-870
19. Tamm I., Kornblau S.M., Segall H., Krajewski S., Welsh K., Kitada S., Scudiero D.A., Tudor G., Qui Y.H., Monks A., Andreeff M., and Reed J.C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 6 (2000) 1796-1803
20. Yan Y., Mahotka C., Heikaus S., Shibata T., Wethkamp N., Liebmann J., Suschek C.V., Guo Y., Gabbert H.E., Gerharz C.D., and Ramp U. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br. J. Cancer 91 (2004) 1349-1357
21. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21 (2001) 3604-3608
22. Cummins J.M., Kohli M., Rago C., Kinzler K.W., Vogelstein B., and Bunz F. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64 (2004) 3006-3008
23. McManus D.C., Lefebvre C.A., Cherton-Horvat G., St-Jean M., Kandimalla E.R., Agrawal S., Morris S.J., Durkin J.P., and Lacasse E.C. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23 (2004) 8105-8117
24. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., de Saint Basile G., and Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 (2006) 110-114
25. Rehm M., Dussmann H., Janicke R.U., Tavare J.M., Kogel D., and Prehn J.H. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J. Biol. Chem. 277 (2002) 24506-24514
26. Tyas L., Brophy V.A., Pope A., Rivett A.J., and Tavare J.M. Rapid caspase-3 activation during apoptosis revealed using fluorescence-resonance energy transfer. EMBO Rep. 1 (2000) 266-270
27. Ehrenberg B., Montana V., Wei M.D., Wuskell J.P., and Loew L.M. Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys. J. 53 (1988) 785-794
28. Ward M.W., Rego A.C., Frenguelli B.G., and Nicholls D.G. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurosci. 20 (2000) 7208-7219
29. Eggert A., Grotzer M.A., Zuzak T.J., Wiewrodt B.R., Ho R., Ikegaki N., and Brodeur G.M. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61 (2001) 1314-1319
30. C. Falschlehner, C.H. Emmerich, B. Gerlach, H. Walczak, TRAIL signalling: decisions between life and death, Int J Biochem Cell Biol (2007).
31. Bentele M., Lavrik I., Ulrich M., Stosser S., Heermann D.W., Kalthoff H., Krammer P.H., and Eils R. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell. Biol. 166 (2004) 839-851
32. Eissing T., Conzelmann H., Gilles E.D., Allgower F., Bullinger E., and Scheurich P. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 279 (2004) 36892-36897
33. Srinivasula S.M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J., Lee R.A., Robbins P.D., Fernandes-Alnemri T., Shi Y., and Alnemri E.S. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410 (2001) 112-116
34. Denault J.B., Eckelman B.P., Shin H., Pop C., and Salvesen G.S. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem. J. 405 (2007) 11-19
35. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., Alnemri E.S., Fairman R., and Shi Y. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell. 11 (2003) 519-527
36. Suzuki Y., Nakabayashi Y., Nakata K., Reed J.C., and Takahashi R. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J. Biol. Chem. 276 (2001) 27058-27063
37. MacFarlane M., Merrison W., Bratton S.B., and Cohen G.M. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277 (2002) 36611-36616
38. Suzuki Y., Nakabayashi Y., and Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad Sci. U S A 98 (2001) 8662-8667
39. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., and Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Embo J. 18 (1999) 5242-5251
40. Silke J., Ekert P.G., Day C.L., Hawkins C.J., Baca M., Chew J., Pakusch M., Verhagen A.M., and Vaux D.L. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. Embo J. 20 (2001) 3114-3123
41. Legewie S., Bluthgen N., and Herzel H. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2 (2006) e120
42. G.P. McStay, G.S. Salvesen, D.R. Green, Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways, Cell. Death Differ. (2007).
43. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., Zhou Q., Ellerby H.M., Ellerby L.M., Bredesen D., Green D.R., Reed J.C., Froelich C.J., and Salvesen G.S. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273 (1998) 27084-27090
44. Sun X.M., Bratton S.B., Butterworth M., MacFarlane M., and Cohen G.M. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277 (2002) 11345-11351
45. Potts P.R., Singh S., Knezek M., Thompson C.B., and Deshmukh M. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J. Cell. Biol. 163 (2003) 789-799
46. Wright K.M., Linhoff M.W., Potts P.R., and Deshmukh M. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J. Cell. Biol. 167 (2004) 303-313
47. Potts M.B., Vaughn A.E., McDonough H., Patterson C., and Deshmukh M. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP. J. Cell. Biol. 171 (2005) 925-930
48. Sharonov G.V., Feofanov A.V., Bocharova O.V., Astapova M.V., Dedukhova V.I., Chernyak B.V., Dolgikh D.A., Arseniev A.S., Skulachev V.P., and Kirpichnikov M.P. Comparative analysis of proapoptotic activity of cytochrome c mutants in living cells. Apoptosis 10 (2005) 797-808
49. Li F., Srinivasan A., Wang Y., Armstrong R.C., Tomaselli K.J., and Fritz L.C. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release. J. Biol. Chem. 272 (1997) 30299-30305
50. Murphy B.M., O'Neill A.J., Adrain C., Watson R.W., and Martin S.J. The apoptosome pathway to caspase activation in primary human neutrophils exhibits dramatically reduced requirements for cytochrome C. J. Exp. Med. 197 (2003) 625-632
51. Conze D.B., Albert L., Ferrick D.A., Goeddel D.V., Yeh W.C., Mak T., and Ashwell J.D. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25 (2005) 3348-3356
52. Eckelman B.P., and Salvesen G.S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281 (2006) 3254-3260
53. Tenev T., Zachariou A., Wilson R., Ditzel M., and Meier P. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat. Cell. Biol. 7 (2005) 70-77
54. Yang Q.H., and Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279 (2004) 16963-16970
55. Yang Y., Fang S., Jensen J.P., Weissman A.M., and Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288 (2000) 874-877
56. Gaither A., Porter D., Yao Y., Borawski J., Yang G., Donovan J., Sage D., Slisz J., Tran M., Straub C., Ramsey T., Iourgenko V., Huang A., Chen Y., Schlegel R., Labow M., Fawell S., Sellers W.R., and Zawel L. A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res. 67 (2007) 11493-11498
57. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., Zobel K., Dynek J.N., Elliott L.O., Wallweber H.J., Flygare J.A., Fairbrother W.J., Deshayes K., Dixit V.M., and Vucic D. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 131 (2007) 669-681
58. Vince J.E., Wong W.W., Khan N., Feltham R., Chau D., Ahmed A.U., Benetatos C.A., Chunduru S.K., Condon S.M., McKinlay M., Brink R., Leverkus M., Tergaonkar V., Schneider P., Callus B.A., Koentgen F., Vaux D.L., and Silke J. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 131 (2007) 682-693
59. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., and Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. Embo J 17 (1998) 1675-1687
60. Sanna M.G., da Silva Correia J., Luo Y., Chuang B., Paulson L.M., Nguyen B., Deveraux Q.L., and Ulevitch R.J. ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J. Biol. Chem. 277 (2002) 30454-30462
61. Sanna M.G., Duckett C.S., Richter B.W., Thompson C.B., and Ulevitch R.J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl. Acad Sci. U S A 95 (1998) 6015-6020
62. Hofer-Warbinek R., Schmid J.A., Stehlik C., Binder B.R., Lipp J., and de Martin R. Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275 (2000) 22064-22068
63. Levkau B., Garton K.J., Ferri N., Kloke K., Nofer J.R., Baba H.A., Raines E.W., and Breithardt G. xIAP induces cell-cycle arrest and activates nuclear factor- kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ. Res. 88 (2001) 282-290
64. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., and Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188 (1998) 211-216
65. Braeuer S.J., Buneker C., Mohr A., and Zwacka R.M. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Mol. Cancer Res. 4 (2006) 715-728
66. Lu M., Lin S.C., Huang Y., Kang Y.J., Rich R., Lo Y.C., Myszka D., Han J., and Wu H. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell. 26 (2007) 689-702